FacultyFaculty/Author Profile

Rujul Desai

Avalere Health LLC

Washington, DC, USA


Rujul Desai, Vice President, advises clients on market access, reimbursement, strategic contracting and regulatory solutions.  He applies his unique combination of experience in specialty pharmacy, biopharma, PBM, legal and regulatory services.  Prior to joining Avalere, Rujul has held a number of leadership roles in the specialty industry, including at CVS Caremark, UCB, and Theracom.  He was also the founder of a specialty hub services company supporting biopharma products.  Rujul has significant health law experience, including practicing at the law firm of K&L Gates.  Rujul holds a JD from University of Houston and a BA from Rutgers University.  He is a combat veteran of the Global War on Terror, U.S. Army, Medical Service Corps, Captain (Ret.).
Rujul Desai is associated with the following items:
CHB Chapters  CHB Chapters Medicare Beneficiaries Will Pay More for Biosimilars than for Their Biologic Reference Products in Part D (April 12, 2016) - Health Care Law Institute 2016: Emerging Challenges and Trends in Reimbursement, Enforcement, Compliance and other Hot Topics, Wednesday, December 14, 2016
Medicare Part B Drug Payments Implicated in CMMI Models - Health Care Law Institute 2016: Emerging Challenges and Trends in Reimbursement, Enforcement, Compliance and other Hot Topics, Wednesday, December 14, 2016
Health Plans Are Interested in Tying Drug Payments to Patient Outcomes (June 16, 2016) - Health Care Law Institute 2016: Emerging Challenges and Trends in Reimbursement, Enforcement, Compliance and other Hot Topics, Wednesday, December 14, 2016
Commercial Uncertainty Remains as U.S. Biosimilar Pipeline Matures - Health Care Law Institute 2016: Emerging Challenges and Trends in Reimbursement, Enforcement, Compliance and other Hot Topics, Wednesday, December 14, 2016
Proposed Medicare Part B Rule Would Reduce Payments to Hospitals and Some Specialists, While Increasing Payments to Primary Care Providers (April 7, 2016) - Health Care Law Institute 2016: Emerging Challenges and Trends in Reimbursement, Enforcement, Compliance and other Hot Topics, Wednesday, December 14, 2016
Web Segment  Web Segment Drug and Biologic Pricing: HotTopics - Health Care Law Institute 2016: Emerging Challenges and Trends in Reimbursement, Enforcement, Compliance and other Hot Topics, Friday, December 16, 2016
MP3 Audio  MP3 Audio Drug and Biologic Pricing: HotTopics - Drug and Biologic Pricing: HotTopics, Friday, December 16, 2016
MP4 - Mobile Video Seg  MP4 - Mobile Video Seg Drug and Biologic Pricing: HotTopics - Drug and Biologic Pricing: HotTopics, Friday, December 16, 2016
On-Demand Web Programs  On-Demand Web Programs Health Care Law Institute 2016: Emerging Challenges and Trends in Reimbursement, Enforcement, Compliance and other Hot Topics, Tuesday, January 03, 2017, New York, NY
Live Seminar  Live Seminar Health Care Law Institute 2017: The New Challenges Facing Providers -- Reimbursement, Enforcement, Compliance, and Other Hot Topics, Thursday, December 14, 2017, New York, NY
Live Webcast  Live Webcast Health Care Law Institute 2017, Thursday, December 14, 2017, New York, NY
PLI Grpcast-Live Web  PLI Grpcast-Live Web Health Care Law Institute 2017: The New Challenges Facing Providers -- Reimbursement, Enforcement, Compliance, and Other Hot Topics, Thursday, December 14, 2017, Atlanta, GA
Health Care Law Institute 2017: The New Challenges Facing Providers -- Reimbursement, Enforcement, Compliance, and Other Hot Topics, Thursday, December 14, 2017, New Brunswick , NJ
Health Care Law Institute 2017: The New Challenges Facing Providers -- Reimbursement, Enforcement, Compliance, and Other Hot Topics, Thursday, December 14, 2017, Nashville, TN
Share
Email

  • FOLLOW PLI:
  • twitter
  • LinkedIn
  • GooglePlus
  • RSS

All Contents Copyright © 1996-2017 Practising Law Institute. Continuing Legal Education since 1933.

© 2017 PLI PRACTISING LAW INSTITUTE. All rights reserved. The PLI logo is a service mark of PLI.